Worth Peripherals Ltd. Board Approves Q1 FY27 Results, Subsidiary Investment & Loan
Worth Peripherals Limited's Board approved Q1 FY27 unaudited results. The company appointed M/s. RS Mantri And Associates as Secretarial Auditor for 5 years. Its subsidiary, Worth Wellness, commenced production. The company converted ₹30 crore loan into equity of its subsidiary and approved a ₹20 crore inter-corporate loan to it.
The approval of quarterly results, commencement of a subsidiary's production, and significant financial transactions (loan conversion and new loan) indicate a positive impact on the company's operational and financial trajectory, warranting a medium impact assessment.
The announcement details positive developments including the approval of financial results, commencement of commercial production by a subsidiary, and strategic financial decisions like loan conversion to equity and provision of inter-corporate loans, indicating growth and operational progress.
Worth Peripherals Limited announced the outcome of its Board Meeting held on August 4, 2026. The Board approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026, along with the Limited Review Report.
The company also approved the appointment of M/s. RS Mantri And Associates as the Secretarial Auditor for a term of five consecutive years, commencing from the conclusion of the ensuing Annual General Meeting until the conclusion of the 35th Annual General Meeting in 2031, subject to shareholders' approval.
Furthermore, Worth Peripherals Limited disclosed that its wholly-owned subsidiary, M/s Worth Wellness Private Limited, commenced commercial production at its new manufacturing facility in Indore, Madhya Pradesh, effective August 1, 2026. This facility is equipped with advanced technology and automation, enhancing the subsidiary's manufacturing capabilities.
In a significant move, the Board approved the acquisition of 60,00,000 equity shares of Worth Wellness Private Limited by the company through the conversion of an outstanding loan of ₹30 crore into equity shares. These shares, with a face value of ₹10 each, were issued at a price of ₹50 per share (including a premium of ₹40).
Additionally, the Board approved an inter-corporate loan of ₹20 crore to Worth Wellness Private Limited, to be utilized for meeting its daily operational funding requirements. The loan is for a period of three years and carries interest at prevailing RBI yield rates, with an option for Worth Peripherals Limited to convert the loan into equity shares of the subsidiary.
The Board Meeting commenced at 11:00 A.M. and concluded at 02:30 P.M. The company will inform the market in due course about the date of the Annual General Meeting for the financial year ended March 31, 2026, and the record date for the Final Dividend and E-Voting.
What to do with a filing like this
Worth Peripherals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Worth Peripherals Limited. Read the original for the full detail.